APO Research
Talk to an analyst

APO RESEARCH · REPORT

Severe Allergy Treatment Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Severe Allergy Treatment Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025195 pages

Choose your research edition.

Industry ResearchSevere Allergy Treatment Injection Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Severe Allergy Treatment Injection Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Severe Allergy Treatment Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Severe Allergy Treatment Injection Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Severe Allergy Treatment Injection Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Severe Allergy Treatment Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Severe Allergy Treatment Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Severe Allergy Treatment Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Severe Allergy Treatment Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Severe Allergy Treatment Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Severe Allergy Treatment Injection include Grand Pharmaceutical Group, Beijing Yongkang Pharmaceutical, Teva Pharmaceutica, TianJin KingYork Group, Shanghai Harvest Pharmaceutical, Viatris, Teligent, Novartis Sandoz and Nephron Pharmaceuticals Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Severe Allergy Treatment Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Severe Allergy Treatment Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Severe Allergy Treatment Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Severe Allergy Treatment Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Severe Allergy Treatment Injection Segment by Company

Grand Pharmaceutical Group

Beijing Yongkang Pharmaceutical

Teva Pharmaceutica

TianJin KingYork Group

Shanghai Harvest Pharmaceutical

Viatris

Teligent

Novartis Sandoz

Nephron Pharmaceuticals Corporation

Livealth Biopharma

Kaléo

Hameln Pharma

Bioprojet Pharma

Bausch Health

Amneal Pharmaceuticals

ALK Abello

AdvaCare Pharma

Adamis Pharmaceuticals Corporation

Severe Allergy Treatment Injection Segment by Type

Epinephrine Auto-Injectors

Epinephrine Hydrochlaride Injection

Others

Severe Allergy Treatment Injection Segment by Application

Over 12 Years Patients

6 to 12 Years Patients

Under 6 Years Patients

Severe Allergy Treatment Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Severe Allergy Treatment Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Severe Allergy Treatment Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Severe Allergy Treatment Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Severe Allergy Treatment Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Severe Allergy Treatment Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Severe Allergy Treatment Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Severe Allergy Treatment Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Severe Allergy Treatment Injection Industry Trends Table 2. Severe Allergy Treatment Injection Industry Drivers Table 3. Severe Allergy Treatment Injection Industry Opportunities and Challenges Table 4. Severe Allergy Treatment Injection Industry Restraints Table 5. Global Severe Allergy Treatment Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Severe Allergy Treatment Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Severe Allergy Treatment Injection Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Severe Allergy Treatment Injection Sales Market Share by Manufacturers Table 9. Global Severe Allergy Treatment Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Severe Allergy Treatment Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Severe Allergy Treatment Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Severe Allergy Treatment Injection Manufacturers, Product Type & Application Table 13. Global Severe Allergy Treatment Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Severe Allergy Treatment Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Epinephrine Auto-Injectors Table 17. Major Manufacturers of Epinephrine Hydrochlaride Injection Table 18. Major Manufacturers of Others Table 19. Global Severe Allergy Treatment Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Severe Allergy Treatment Injection Sales by Type (2021-2026) & (K Units) Table 21. Global Severe Allergy Treatment Injection Sales by Type (2027-2032) & (K Units) Table 22. Global Severe Allergy Treatment Injection Sales Market Share by Type (2021-2026) Table 23. Global Severe Allergy Treatment Injection Sales Market Share by Type (2027-2032) Table 24. Global Severe Allergy Treatment Injection Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Severe Allergy Treatment Injection Revenue by Type (2021-2026) & (K Units) Table 26. Global Severe Allergy Treatment Injection Revenue by Type (2027-2032) & (K Units) Table 27. Global Severe Allergy Treatment Injection Revenue Market Share by Type (2021-2026) Table 28. Global Severe Allergy Treatment Injection Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Over 12 Years Patients Table 30. Major Manufacturers of 6 to 12 Years Patients Table 31. Major Manufacturers of Under 6 Years Patients Table 32. Global Severe Allergy Treatment Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Severe Allergy Treatment Injection Sales by Application (2021-2026) & (K Units) Table 34. Global Severe Allergy Treatment Injection Sales by Application (2027-2032) & (K Units) Table 35. Global Severe Allergy Treatment Injection Sales Market Share by Application (2021-2026) Table 36. Global Severe Allergy Treatment Injection Sales Market Share by Application (2027-2032) Table 37. Global Severe Allergy Treatment Injection Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Severe Allergy Treatment Injection Revenue by Application (2021-2026) & (K Units) Table 39. Global Severe Allergy Treatment Injection Revenue by Application (2027-2032) & (K Units) Table 40. Global Severe Allergy Treatment Injection Revenue Market Share by Application (2021-2026) Table 41. Global Severe Allergy Treatment Injection Revenue Market Share by Application (2027-2032) Table 42. Global Severe Allergy Treatment Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Severe Allergy Treatment Injection Sales by Region (2021-2026) & (K Units) Table 44. Global Severe Allergy Treatment Injection Sales Market Share by Region (2021-2026) Table 45. Global Severe Allergy Treatment Injection Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Severe Allergy Treatment Injection Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Severe Allergy Treatment Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Severe Allergy Treatment Injection Sales by Country (2021-2026) & (K Units) Table 49. North America Severe Allergy Treatment Injection Sales by Country (2027-2032) & (K Units) Table 50. Europe Severe Allergy Treatment Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Severe Allergy Treatment Injection Sales by Country (2021-2026) & (K Units) Table 52. Europe Severe Allergy Treatment Injection Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Severe Allergy Treatment Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Severe Allergy Treatment Injection Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Severe Allergy Treatment Injection Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Severe Allergy Treatment Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Severe Allergy Treatment Injection Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Severe Allergy Treatment Injection Sales by Country (2027-2032) & (K Units) Table 59. Global Severe Allergy Treatment Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Severe Allergy Treatment Injection Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Severe Allergy Treatment Injection Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Severe Allergy Treatment Injection Revenue Market Share by Region (2021-2026) Table 63. Global Severe Allergy Treatment Injection Revenue Market Share by Region (2027-2032) Table 64. Grand Pharmaceutical Group Company Information Table 65. Grand Pharmaceutical Group Business Overview Table 66. Grand Pharmaceutical Group Severe Allergy Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Grand Pharmaceutical Group Severe Allergy Treatment Injection Product Portfolio Table 68. Grand Pharmaceutical Group Recent Development Table 69. Beijing Yongkang Pharmaceutical Company Information Table 70. Beijing Yongkang Pharmaceutical Business Overview Table 71. Beijing Yongkang Pharmaceutical Severe Allergy Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Beijing Yongkang Pharmaceutical Severe Allergy Treatment Injection Product Portfolio Table 73. Beijing Yongkang Pharmaceutical Recent Development Table 74. Teva Pharmaceutica Company Information Table 75. Teva Pharmaceutica Business Overview Table 76. Teva Pharmaceutica Severe Allergy Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Teva Pharmaceutica Severe Allergy Treatment Injection Product Portfolio Table 78. Teva Pharmaceutica Recent Development Table 79. TianJin KingYork Group Company Information Table 80. TianJin KingYork Group Business Overview Table 81. TianJin KingYork Group Severe Allergy Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. TianJin KingYork Group Severe Allergy Treatment Injection Product Portfolio Table 83. TianJin KingYork Group Recent Development Table 84. Shanghai Harvest Pharmaceutical Company Information Table 85. Shanghai Harvest Pharmaceutical Business Overview Table 86. Shanghai Harvest Pharmaceutical Severe Allergy Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Shanghai Harvest Pharmaceutical Severe Allergy Treatment Injection Product Portfolio Table 88. Shanghai Harvest Pharmaceutical Recent Development Table 89. Viatris Company Information Table 90. Viatris Business Overview Table 91. Viatris Severe Allergy Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Viatris Severe Allergy Treatment Injection Product Portfolio Table 93. Viatris Recent Development Table 94. Teligent Company Information Table 95. Teligent Business Overview Table 96. Teligent Severe Allergy Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Teligent Severe Allergy Treatment Injection Product Portfolio Table 98. Teligent Recent Development Table 99. Novartis Sandoz Company Information Table 100. Novartis Sandoz Business Overview Table 101. Novartis Sandoz Severe Allergy Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Novartis Sandoz Severe Allergy Treatment Injection Product Portfolio Table 103. Novartis Sandoz Recent Development Table 104. Nephron Pharmaceuticals Corporation Company Information Table 105. Nephron Pharmaceuticals Corporation Business Overview Table 106. Nephron Pharmaceuticals Corporation Severe Allergy Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Nephron Pharmaceuticals Corporation Severe Allergy Treatment Injection Product Portfolio Table 108. Nephron Pharmaceuticals Corporation Recent Development Table 109. Livealth Biopharma Company Information Table 110. Livealth Biopharma Business Overview Table 111. Livealth Biopharma Severe Allergy Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Livealth Biopharma Severe Allergy Treatment Injection Product Portfolio Table 113. Livealth Biopharma Recent Development Table 114. Kaléo Company Information Table 115. Kaléo Business Overview Table 116. Kaléo Severe Allergy Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Kaléo Severe Allergy Treatment Injection Product Portfolio Table 118. Kaléo Recent Development Table 119. Hameln Pharma Company Information Table 120. Hameln Pharma Business Overview Table 121. Hameln Pharma Severe Allergy Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Hameln Pharma Severe Allergy Treatment Injection Product Portfolio Table 123. Hameln Pharma Recent Development Table 124. Bioprojet Pharma Company Information Table 125. Bioprojet Pharma Business Overview Table 126. Bioprojet Pharma Severe Allergy Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Bioprojet Pharma Severe Allergy Treatment Injection Product Portfolio Table 128. Bioprojet Pharma Recent Development Table 129. Bausch Health Company Information Table 130. Bausch Health Business Overview Table 131. Bausch Health Severe Allergy Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Bausch Health Severe Allergy Treatment Injection Product Portfolio Table 133. Bausch Health Recent Development Table 134. Amneal Pharmaceuticals Company Information Table 135. Amneal Pharmaceuticals Business Overview Table 136. Amneal Pharmaceuticals Severe Allergy Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Amneal Pharmaceuticals Severe Allergy Treatment Injection Product Portfolio Table 138. Amneal Pharmaceuticals Recent Development Table 139. ALK Abello Company Information Table 140. ALK Abello Business Overview Table 141. ALK Abello Severe Allergy Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. ALK Abello Severe Allergy Treatment Injection Product Portfolio Table 143. ALK Abello Recent Development Table 144. AdvaCare Pharma Company Information Table 145. AdvaCare Pharma Business Overview Table 146. AdvaCare Pharma Severe Allergy Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. AdvaCare Pharma Severe Allergy Treatment Injection Product Portfolio Table 148. AdvaCare Pharma Recent Development Table 149. Adamis Pharmaceuticals Corporation Company Information Table 150. Adamis Pharmaceuticals Corporation Business Overview Table 151. Adamis Pharmaceuticals Corporation Severe Allergy Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. Adamis Pharmaceuticals Corporation Severe Allergy Treatment Injection Product Portfolio Table 153. Adamis Pharmaceuticals Corporation Recent Development Table 154. Key Raw Materials Table 155. Raw Materials Key Suppliers Table 156. Severe Allergy Treatment Injection Distributors List Table 157. Severe Allergy Treatment Injection Customers List Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Severe Allergy Treatment Injection Product Image Figure 2. Global Severe Allergy Treatment Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Severe Allergy Treatment Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Severe Allergy Treatment Injection Sales (2021-2032) & (K Units) Figure 5. Global Severe Allergy Treatment Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Severe Allergy Treatment Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Epinephrine Auto-Injectors Image Figure 9. Epinephrine Hydrochlaride Injection Image Figure 10. Others Image Figure 11. Global Severe Allergy Treatment Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Severe Allergy Treatment Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Severe Allergy Treatment Injection Sales Market Share by Type (2021-2032) Figure 14. Global Severe Allergy Treatment Injection Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Severe Allergy Treatment Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Severe Allergy Treatment Injection Revenue Market Share by Type (2021-2032) Figure 17. Over 12 Years Patients Image Figure 18. 6 to 12 Years Patients Image Figure 19. Under 6 Years Patients Image Figure 20. Global Severe Allergy Treatment Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Severe Allergy Treatment Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Severe Allergy Treatment Injection Sales Market Share by Application (2021-2032) Figure 23. Global Severe Allergy Treatment Injection Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Severe Allergy Treatment Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Severe Allergy Treatment Injection Revenue Market Share by Application (2021-2032) Figure 26. North America Severe Allergy Treatment Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Severe Allergy Treatment Injection Sales Market Share by Country (2021-2032) Figure 28. U.S. Severe Allergy Treatment Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Severe Allergy Treatment Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Severe Allergy Treatment Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Severe Allergy Treatment Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Severe Allergy Treatment Injection Sales Market Share by Country (2021-2032) Figure 33. Germany Severe Allergy Treatment Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Severe Allergy Treatment Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Severe Allergy Treatment Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Severe Allergy Treatment Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Severe Allergy Treatment Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Severe Allergy Treatment Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Severe Allergy Treatment Injection Sales Market Share by Country (2021-2032) Figure 40. China Severe Allergy Treatment Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Severe Allergy Treatment Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Severe Allergy Treatment Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Severe Allergy Treatment Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Severe Allergy Treatment Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Severe Allergy Treatment Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Severe Allergy Treatment Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Severe Allergy Treatment Injection Sales Market Share by Country (2021-2032) Figure 48. Brazil Severe Allergy Treatment Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Severe Allergy Treatment Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Severe Allergy Treatment Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Severe Allergy Treatment Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Severe Allergy Treatment Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Severe Allergy Treatment Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Severe Allergy Treatment Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Severe Allergy Treatment Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Severe Allergy Treatment Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Severe Allergy Treatment Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Severe Allergy Treatment Injection Revenue (2021-2032) & (US$ Million) Figure 59. North America Severe Allergy Treatment Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Severe Allergy Treatment Injection Revenue (2021-2032) & (US$ Million) Figure 61. Europe Severe Allergy Treatment Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Severe Allergy Treatment Injection Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Severe Allergy Treatment Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Severe Allergy Treatment Injection Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Severe Allergy Treatment Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Severe Allergy Treatment Injection Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Severe Allergy Treatment Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Epinephrine Auto-Injectors
  • Epinephrine Hydrochlaride Injection
  • Others
Applications
  • Over 12 Years Patients
  • 6 to 12 Years Patients
  • Under 6 Years Patients
Companies covered
  • Grand Pharmaceutical Group
  • Beijing Yongkang Pharmaceutical
  • Teva Pharmaceutica
  • TianJin KingYork Group
  • Shanghai Harvest Pharmaceutical
  • Viatris
  • Teligent
  • Novartis Sandoz
  • Nephron Pharmaceuticals Corporation
  • Livealth Biopharma
  • Kaléo
  • Hameln Pharma
  • Bioprojet Pharma
  • Bausch Health
  • Amneal Pharmaceuticals
  • ALK Abello
  • AdvaCare Pharma
  • Adamis Pharmaceuticals Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Severe Allergy Treatment Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Severe Allergy Treatment Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Severe Allergy Treatment Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Severe Allergy Treatment Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Severe Allergy Treatment Injection Market Dynamics
  1. 2.1 Severe Allergy Treatment Injection Industry Trends
  2. 2.2 Severe Allergy Treatment Injection Industry Drivers
  3. 2.3 Severe Allergy Treatment Injection Industry Opportunities and Challenges
  4. 2.4 Severe Allergy Treatment Injection Industry Restraints
3 Severe Allergy Treatment Injection Market by Manufacturers
  1. 3.1 Global Severe Allergy Treatment Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Severe Allergy Treatment Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Severe Allergy Treatment Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Severe Allergy Treatment Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Severe Allergy Treatment Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Severe Allergy Treatment Injection Manufacturers, Product Type & Application
  7. 3.7 Global Severe Allergy Treatment Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Severe Allergy Treatment Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Severe Allergy Treatment Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Severe Allergy Treatment Injection Tier 1, Tier 2, and Tier 3
4 Severe Allergy Treatment Injection Market by Type
  1. 4.1 Severe Allergy Treatment Injection Type Introduction
  2. 4.1.1 Epinephrine Auto-Injectors
  3. 4.1.2 Epinephrine Hydrochlaride Injection
  4. 4.1.3 Others
  5. 4.2 Global Severe Allergy Treatment Injection Sales by Type
  6. 4.2.1 Global Severe Allergy Treatment Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Severe Allergy Treatment Injection Sales by Type (2021-2032)
  8. 4.2.3 Global Severe Allergy Treatment Injection Sales Market Share by Type (2021-2032)
  9. 4.3 Global Severe Allergy Treatment Injection Revenue by Type
  10. 4.3.1 Global Severe Allergy Treatment Injection Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Severe Allergy Treatment Injection Revenue by Type (2021-2032)
  12. 4.3.3 Global Severe Allergy Treatment Injection Revenue Market Share by Type (2021-2032)
5 Severe Allergy Treatment Injection Market by Application
  1. 5.1 Severe Allergy Treatment Injection Application Introduction
  2. 5.1.1 Over 12 Years Patients
  3. 5.1.2 6 to 12 Years Patients
  4. 5.1.3 Under 6 Years Patients
  5. 5.2 Global Severe Allergy Treatment Injection Sales by Application
  6. 5.2.1 Global Severe Allergy Treatment Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Severe Allergy Treatment Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Severe Allergy Treatment Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Severe Allergy Treatment Injection Revenue by Application
  10. 5.3.1 Global Severe Allergy Treatment Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Severe Allergy Treatment Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Severe Allergy Treatment Injection Revenue Market Share by Application (2021-2032)
6 Global Severe Allergy Treatment Injection Sales by Region
  1. 6.1 Global Severe Allergy Treatment Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Severe Allergy Treatment Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Severe Allergy Treatment Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Severe Allergy Treatment Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Severe Allergy Treatment Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Severe Allergy Treatment Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Severe Allergy Treatment Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Severe Allergy Treatment Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Severe Allergy Treatment Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Severe Allergy Treatment Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Severe Allergy Treatment Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Severe Allergy Treatment Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Severe Allergy Treatment Injection Revenue by Region
  1. 7.1 Global Severe Allergy Treatment Injection Revenue by Region
  2. 7.1.1 Global Severe Allergy Treatment Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Severe Allergy Treatment Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Severe Allergy Treatment Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Severe Allergy Treatment Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Severe Allergy Treatment Injection Revenue (2021-2032)
  8. 7.2.2 North America Severe Allergy Treatment Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Severe Allergy Treatment Injection Revenue (2021-2032)
  11. 7.3.2 Europe Severe Allergy Treatment Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Severe Allergy Treatment Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Severe Allergy Treatment Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Severe Allergy Treatment Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Severe Allergy Treatment Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Grand Pharmaceutical Group
  2. 8.1.1 Grand Pharmaceutical Group Company Information
  3. 8.1.2 Grand Pharmaceutical Group Business Overview
  4. 8.1.3 Grand Pharmaceutical Group Severe Allergy Treatment Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Grand Pharmaceutical Group Severe Allergy Treatment Injection Product Portfolio
  6. 8.1.5 Grand Pharmaceutical Group Recent Developments
  7. 8.2 Beijing Yongkang Pharmaceutical
  8. 8.2.1 Beijing Yongkang Pharmaceutical Company Information
  9. 8.2.2 Beijing Yongkang Pharmaceutical Business Overview
  10. 8.2.3 Beijing Yongkang Pharmaceutical Severe Allergy Treatment Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Beijing Yongkang Pharmaceutical Severe Allergy Treatment Injection Product Portfolio
  12. 8.2.5 Beijing Yongkang Pharmaceutical Recent Developments
  13. 8.3 Teva Pharmaceutica
  14. 8.3.1 Teva Pharmaceutica Company Information
  15. 8.3.2 Teva Pharmaceutica Business Overview
  16. 8.3.3 Teva Pharmaceutica Severe Allergy Treatment Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Teva Pharmaceutica Severe Allergy Treatment Injection Product Portfolio
  18. 8.3.5 Teva Pharmaceutica Recent Developments
  19. 8.4 TianJin KingYork Group
  20. 8.4.1 TianJin KingYork Group Company Information
  21. 8.4.2 TianJin KingYork Group Business Overview
  22. 8.4.3 TianJin KingYork Group Severe Allergy Treatment Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 TianJin KingYork Group Severe Allergy Treatment Injection Product Portfolio
  24. 8.4.5 TianJin KingYork Group Recent Developments
  25. 8.5 Shanghai Harvest Pharmaceutical
  26. 8.5.1 Shanghai Harvest Pharmaceutical Company Information
  27. 8.5.2 Shanghai Harvest Pharmaceutical Business Overview
  28. 8.5.3 Shanghai Harvest Pharmaceutical Severe Allergy Treatment Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shanghai Harvest Pharmaceutical Severe Allergy Treatment Injection Product Portfolio
  30. 8.5.5 Shanghai Harvest Pharmaceutical Recent Developments
  31. 8.6 Viatris
  32. 8.6.1 Viatris Company Information
  33. 8.6.2 Viatris Business Overview
  34. 8.6.3 Viatris Severe Allergy Treatment Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Viatris Severe Allergy Treatment Injection Product Portfolio
  36. 8.6.5 Viatris Recent Developments
  37. 8.7 Teligent
  38. 8.7.1 Teligent Company Information
  39. 8.7.2 Teligent Business Overview
  40. 8.7.3 Teligent Severe Allergy Treatment Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Teligent Severe Allergy Treatment Injection Product Portfolio
  42. 8.7.5 Teligent Recent Developments
  43. 8.8 Novartis Sandoz
  44. 8.8.1 Novartis Sandoz Company Information
  45. 8.8.2 Novartis Sandoz Business Overview
  46. 8.8.3 Novartis Sandoz Severe Allergy Treatment Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Novartis Sandoz Severe Allergy Treatment Injection Product Portfolio
  48. 8.8.5 Novartis Sandoz Recent Developments
  49. 8.9 Nephron Pharmaceuticals Corporation
  50. 8.9.1 Nephron Pharmaceuticals Corporation Company Information
  51. 8.9.2 Nephron Pharmaceuticals Corporation Business Overview
  52. 8.9.3 Nephron Pharmaceuticals Corporation Severe Allergy Treatment Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Nephron Pharmaceuticals Corporation Severe Allergy Treatment Injection Product Portfolio
  54. 8.9.5 Nephron Pharmaceuticals Corporation Recent Developments
  55. 8.10 Livealth Biopharma
  56. 8.10.1 Livealth Biopharma Company Information
  57. 8.10.2 Livealth Biopharma Business Overview
  58. 8.10.3 Livealth Biopharma Severe Allergy Treatment Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Livealth Biopharma Severe Allergy Treatment Injection Product Portfolio
  60. 8.10.5 Livealth Biopharma Recent Developments
  61. 8.11 Kaléo
  62. 8.11.1 Kaléo Company Information
  63. 8.11.2 Kaléo Business Overview
  64. 8.11.3 Kaléo Severe Allergy Treatment Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Kaléo Severe Allergy Treatment Injection Product Portfolio
  66. 8.11.5 Kaléo Recent Developments
  67. 8.12 Hameln Pharma
  68. 8.12.1 Hameln Pharma Company Information
  69. 8.12.2 Hameln Pharma Business Overview
  70. 8.12.3 Hameln Pharma Severe Allergy Treatment Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hameln Pharma Severe Allergy Treatment Injection Product Portfolio
  72. 8.12.5 Hameln Pharma Recent Developments
  73. 8.13 Bioprojet Pharma
  74. 8.13.1 Bioprojet Pharma Company Information
  75. 8.13.2 Bioprojet Pharma Business Overview
  76. 8.13.3 Bioprojet Pharma Severe Allergy Treatment Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Bioprojet Pharma Severe Allergy Treatment Injection Product Portfolio
  78. 8.13.5 Bioprojet Pharma Recent Developments
  79. 8.14 Bausch Health
  80. 8.14.1 Bausch Health Company Information
  81. 8.14.2 Bausch Health Business Overview
  82. 8.14.3 Bausch Health Severe Allergy Treatment Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bausch Health Severe Allergy Treatment Injection Product Portfolio
  84. 8.14.5 Bausch Health Recent Developments
  85. 8.15 Amneal Pharmaceuticals
  86. 8.15.1 Amneal Pharmaceuticals Company Information
  87. 8.15.2 Amneal Pharmaceuticals Business Overview
  88. 8.15.3 Amneal Pharmaceuticals Severe Allergy Treatment Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Amneal Pharmaceuticals Severe Allergy Treatment Injection Product Portfolio
  90. 8.15.5 Amneal Pharmaceuticals Recent Developments
  91. 8.16 ALK Abello
  92. 8.16.1 ALK Abello Company Information
  93. 8.16.2 ALK Abello Business Overview
  94. 8.16.3 ALK Abello Severe Allergy Treatment Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 ALK Abello Severe Allergy Treatment Injection Product Portfolio
  96. 8.16.5 ALK Abello Recent Developments
  97. 8.17 AdvaCare Pharma
  98. 8.17.1 AdvaCare Pharma Company Information
  99. 8.17.2 AdvaCare Pharma Business Overview
  100. 8.17.3 AdvaCare Pharma Severe Allergy Treatment Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 AdvaCare Pharma Severe Allergy Treatment Injection Product Portfolio
  102. 8.17.5 AdvaCare Pharma Recent Developments
  103. 8.18 Adamis Pharmaceuticals Corporation
  104. 8.18.1 Adamis Pharmaceuticals Corporation Company Information
  105. 8.18.2 Adamis Pharmaceuticals Corporation Business Overview
  106. 8.18.3 Adamis Pharmaceuticals Corporation Severe Allergy Treatment Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Adamis Pharmaceuticals Corporation Severe Allergy Treatment Injection Product Portfolio
  108. 8.18.5 Adamis Pharmaceuticals Corporation Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Severe Allergy Treatment Injection Value Chain Analysis
  2. 9.1.1 Severe Allergy Treatment Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Severe Allergy Treatment Injection Production Mode & Process
  6. 9.2 Severe Allergy Treatment Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Severe Allergy Treatment Injection Distributors
  9. 9.2.3 Severe Allergy Treatment Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst